Zymeworks (ZYME) Current Assets (2021 - 2026)
Zymeworks (ZYME) reported Current Assets of $298.39 million for Q2 2026, up 0.8% from $296.13 million a year earlier but down 22.6% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Zymeworks posted Current Assets of $248.77 million, down 17.2% from FY2024.
- Current Assets has declined for three consecutive years, with a four-year compound annual growth rate of -3.6% (FY2021 to FY2025).
- By year, Current Assets came in at $300.45 million in FY2024 (-27.2%), $412.93 million in FY2023 (-24.2%), $544.71 million in FY2022 (+89.0%) and $288.22 million in FY2021.
- Five-year quarterly Current Assets spans a low of $190.66 million in Q3 2022 and a high of $544.71 million in Q4 2022.
- Year over year, Current Assets gained in two of the last eight quarters, with an average decline of 10.8%.
- The high point for year-over-year Current Assets in five years was Q3 2023 (growth of 96.5%); the low point was Q4 2024 (a decline of 27.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $385.68 million (Q1 2026), $248.77 million (Q4 2025) and $291.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Zymeworks | 1.94 Bn | 820.54 Mn | - | 298.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 298.39 Mn |
| Mar 31, 2026 | 385.68 Mn |
| Dec 31, 2025 | 248.77 Mn |
| Sep 30, 2025 | 291.71 Mn |
| Jun 30, 2025 | 296.13 Mn |
| Mar 31, 2025 | 306.47 Mn |
| Dec 31, 2024 | 300.45 Mn |
| Sep 30, 2024 | 343.77 Mn |
| Jun 30, 2024 | 383.50 Mn |
| Mar 31, 2024 | 393.82 Mn |
| Dec 31, 2023 | 412.93 Mn |
| Sep 30, 2023 | 374.63 Mn |
| Jun 30, 2023 | 420.34 Mn |
| Mar 31, 2023 | 426.37 Mn |
| Dec 31, 2022 | 544.71 Mn |
| Sep 30, 2022 | 190.66 Mn |
| Dec 31, 2021 | 288.22 Mn |
API Access
Zymeworks Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();